A DEA listening to on shifting marijuana to Schedule III runs via July 15, with hashish ETF MSOS already sitting at 2026 highs heading into the choice.
Investorideas.com (www.investorideas.com) a go-to platform for large investing concepts, together with hashish shares, points a buying and selling and information alert on the DEA’s hashish rescheduling listening to forward of its July 15 deadline.
What the Listening to May Change
The Drug Enforcement Administration started an expedited listening to on June 29 to resolve whether or not to maneuver marijuana, together with grownup use hashish, from Schedule I to Schedule III of the Managed Substances Act, with a deadline to conclude by July 15, in response to Forbes and legislation agency Ropes and Grey. The listening to follows an April 23 order from Performing Lawyer Common Todd Blanche that already reclassified FDA authorised and state licensed medical hashish merchandise to Schedule III, eliminating IRS Code 280E tax penalties for licensed medical operators, per Hashish Enterprise Occasions.
Advocacy teams together with NORML and NCIA have criticized the listening to’s construction, which they are saying permits testimony solely from events against rescheduling, in response to Forbes. Authorized danger additionally stays dwell. Petitioners have requested the D.C. Circuit to remain the April order, with the Division of Justice’s response due July 2.
Commercial
Hashish Equities Are Already Pricing In Optimism
Forward of the listening to, the AdvisorShares Pure US Hashish ETF, ticker MSOS, hit its highest ranges of 2026, delivering a 103.7% one 12 months web asset worth return as of Might 31 and managing $1.13 billion in belongings as of June 5, with Trulieve its largest holding at about 30% of belongings, in response to Stocktwits. Trulieve started buying and selling on the NYSE underneath the ticker TRLV, and Curaleaf accomplished a 1 for 3 reverse break up round June 5 to arrange for a possible U.S. trade uplisting, per Stocktwits and Curaleaf’s SEC submitting.
Backside Line
A tough regulatory deadline mixed with an ETF already sitting at 2026 highs means the subsequent two weeks carry extra binary danger for hashish equities than nearly every other sector InvestorIdeas covers. The July 2 DOJ submitting and the July 15 listening to conclusion are the 2 dates to look at earlier than any rescheduling determination strikes the group meaningfully in both path.
Frequent Questions
What’s the DEA hashish rescheduling listening to and why does it matter for hashish shares? The DEA is holding a listening to via July 15 on whether or not to maneuver marijuana from Schedule I to Schedule III of the Managed Substances Act, a choice that will prolong tax aid already granted to medical operators to the broader trade, together with grownup use hashish firms.
What modified for hashish firms in April 2026? An April 23 order from Performing Lawyer Common Todd Blanche reclassified FDA authorised and state licensed medical hashish merchandise to Schedule III, eliminating IRS Code 280E tax penalties for licensed medical operators.
How has the hashish ETF MSOS carried out forward of the listening to? MSOS hit its highest ranges of 2026 forward of the listening to, delivering a 103.7% one 12 months web asset worth return as of Might 31 and managing $1.13 billion in belongings as of June 5.
What’s the subsequent authorized deadline for hashish rescheduling? The Division of Justice’s response to a authorized problem in search of to remain the April 23 reclassification order is due July 2, forward of the DEA listening to’s July 15 conclusion deadline.
Browse licensed hashish operators and MSO protection on InvestorIdeas’ hashish shares listing.
Disclaimer/Disclosure: Our web site doesn’t make suggestions for purchases or sale of shares, providers or merchandise. Nothing on our websites needs to be construed as a proposal or solicitation to purchase or promote merchandise or securities. All investing includes danger and attainable losses. This web site is presently compensated for information publication and distribution, social media and advertising, content material creation and extra. Disclosure is posted for every compensated information launch, content material revealed/created if required however in any other case the information was not compensated for and was revealed for the only curiosity of our readers and followers. Contact administration and IR of every firm immediately concerning particular questions.
Extra disclaimer and disclosure data: https://www.investorideas.com/About/Disclaimer.asp
International buyers should adhere to rules of every nation. Please learn Investorideas.com privateness coverage: https://www.investorideas.com/About/Private_Policy.asp
